144 related articles for article (PubMed ID: 2543743)
1. Characterization of a DNA polymerase mutant of herpes simplex virus from a severely immunocompromised patient receiving acyclovir.
Collins P; Larder BA; Oliver NM; Kemp S; Smith IW; Darby G
J Gen Virol; 1989 Feb; 70 ( Pt 2)():375-82. PubMed ID: 2543743
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
Schmit I; Boivin G
J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
[TBL] [Abstract][Full Text] [Related]
3. Acyclovir-resistant herpes simplex virus infection due to altered DNA polymerase.
Parker AC; Craig JI; Collins P; Oliver N; Smith I
Lancet; 1987 Dec; 2(8573):1461. PubMed ID: 2892018
[No Abstract] [Full Text] [Related]
4. Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity?
Sacks SL; Wanklin RJ; Reece DE; Hicks KA; Tyler KL; Coen DM
Ann Intern Med; 1989 Dec; 111(11):893-9. PubMed ID: 2554768
[TBL] [Abstract][Full Text] [Related]
5. Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.
Arnulf B; Chebbi F; Lefrere F; Ait Arkoub Z; Varet B; Fillet AM
Bone Marrow Transplant; 2001 Oct; 28(8):799-801. PubMed ID: 11781635
[TBL] [Abstract][Full Text] [Related]
6. A point mutation within a distinct conserved region of the herpes simplex virus DNA polymerase gene confers drug resistance.
Hwang CB; Ruffner KL; Coen DM
J Virol; 1992 Mar; 66(3):1774-6. PubMed ID: 1310779
[TBL] [Abstract][Full Text] [Related]
7. Drug resistance patterns of herpes simplex virus isolates from patients treated with acyclovir.
McLaren C; Chen MS; Ghazzouli I; Saral R; Burns WH
Antimicrob Agents Chemother; 1985 Dec; 28(6):740-4. PubMed ID: 3002245
[TBL] [Abstract][Full Text] [Related]
8. Acyclovir-resistant mutants of herpes simplex virus type 1 express altered DNA polymerase or reduced acyclovir phosphorylating activities.
Furman PA; Coen DM; St Clair MH; Schaffer PA
J Virol; 1981 Dec; 40(3):936-41. PubMed ID: 6275127
[TBL] [Abstract][Full Text] [Related]
9. Successful foscarnet therapy for mucocutaneous infection with herpes simplex virus in a recipient after unrelated bone marrow transplantation.
Iino T; Gondo H; Ohno Y; Minagawa H; Iwasaki H; Maruyama T; Nakashima H; Niho Y
Bone Marrow Transplant; 1996 Dec; 18(6):1185-8. PubMed ID: 8971394
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
[TBL] [Abstract][Full Text] [Related]
11. Sequential switching of DNA polymerase and thymidine kinase-mediated HSV-1 drug resistance in an immunocompromised child.
Stránská R; van Loon AM; Bredius RG; Polman M; Nienhuis E; Beersma MF; Lankester AC; Schuurman R
Antivir Ther; 2004 Feb; 9(1):97-104. PubMed ID: 15040541
[TBL] [Abstract][Full Text] [Related]
12. [Resistance of herpes simplex viruses to antiviral drugs].
Scieux C; Bianchi A
Pathol Biol (Paris); 1993 Feb; 41(2):172-7. PubMed ID: 8392160
[TBL] [Abstract][Full Text] [Related]
13. Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activities.
Larder BA; Darby G
Virology; 1985 Oct; 146(2):262-71. PubMed ID: 2996220
[TBL] [Abstract][Full Text] [Related]
14. The herpes simplex virus type 1 DNA polymerase gene: site of phosphonoacetic acid resistance mutation in strain Angelotti is highly conserved.
Knopf CW
J Gen Virol; 1987 May; 68 ( Pt 5)():1429-33. PubMed ID: 3033142
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and genetic analysis of acyclovir-resistant mutants of herpes simplex virus type 1.
Coen DM; Schaffer PA; Furman PA; Keller PM; St Clair MH
Am J Med; 1982 Jul; 73(1A):351-60. PubMed ID: 6285722
[No Abstract] [Full Text] [Related]
16. Biological and biochemical characterization of clinical isolates of herpes simplex virus type 2 resistant to acyclovir.
Oliver NM; Collins P; Van der Meer J; Van't Wout JW
Antimicrob Agents Chemother; 1989 May; 33(5):635-40. PubMed ID: 2546486
[TBL] [Abstract][Full Text] [Related]
17. [Genotyping diagnosis of acyclovir resistant herpes simplex virus].
Frobert E; Thouvenot D; Lina B; Morfin F
Pathol Biol (Paris); 2007 Dec; 55(10):504-11. PubMed ID: 17920786
[TBL] [Abstract][Full Text] [Related]
18. Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir.
Wade JC; McLaren C; Meyers JD
J Infect Dis; 1983 Dec; 148(6):1077-82. PubMed ID: 6317768
[TBL] [Abstract][Full Text] [Related]
19. Recurrent herpes simplex virus hepatitis after liver retransplantation despite acyclovir therapy.
Longerich T; Eisenbach C; Penzel R; Kremer T; Flechtenmacher C; Helmke B; Encke J; Kraus T; Schirmacher P
Liver Transpl; 2005 Oct; 11(10):1289-94. PubMed ID: 16184558
[TBL] [Abstract][Full Text] [Related]
20. Genetic mechanisms of resistance to acyclovir in herpes simplex virus.
Crumpacker CS; Schnipper LE; Chartrand P; Knopf KW
Am J Med; 1982 Jul; 73(1A):361-8. PubMed ID: 6285723
[No Abstract] [Full Text] [Related]
[Next] [New Search]
